Cargando…
The Effect of Far-Infrared Therapy on the Peritoneal Expression of Glucose Degradation Products in Diabetic Patients on Peritoneal Dialysis
Peritoneal dialysis (PD) is a treatment modality for end-stage renal disease (ESRD) patients. Dextrose is a common osmotic agent used in PD solutions and its absorption may exacerbate diabetes mellitus, a common complication of ESRD. PD solutions also contain glucose degradation products (GDPs) that...
Autores principales: | Chang, Chia-Ning, Niu, Chih-Yuan, Tan, Ann Charis, Chan, Chia-Hao, Chen, Chun-Fan, Chen, Tz-Heng, Li, Szu-Yuan, Chen, Yung-Tai, Chen, Fan-Yu, Liu, Wen-Sheng, Lin, Chih-Ching, Wei, Guor-Jien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038268/ https://www.ncbi.nlm.nih.gov/pubmed/33918516 http://dx.doi.org/10.3390/ijms22073732 |
Ejemplares similares
-
The Effect of Far-Infrared Therapy on the Peritoneal Membrane Transport Characteristics of Uremic Patients Undergoing Peritoneal Dialysis: An Open-Prospective Proof-of-Concept Study
por: Li, Ching-Po, et al.
Publicado: (2021) -
Baseline Peritoneal Membrane Transport Characteristics Are Associated with Peritonitis Risk in Incident Peritoneal Dialysis Patients
por: Chou, Yi-Hsin, et al.
Publicado: (2022) -
Does Far-Infrared Therapy Improve Peritoneal Function and Reduce Recurrent Peritonitis in Peritoneal Dialysis Patients?
por: Chang, Yuanmay, et al.
Publicado: (2022) -
Peritoneal-Membrane Characteristics and Hypervolemia Management in Peritoneal Dialysis: A Randomized Control Trial
por: Li, Szu-Yuan, et al.
Publicado: (2021) -
Citrobacter Peritoneal Dialysis Peritonitis: Rare Occurrence with Poor Outcomes
por: Chao, Chia-Ter, et al.
Publicado: (2013)